Vecchierini, Marie-Françoise
,
Attali, Valérie
Collet, Jean-Marc
d’Ortho, Marie-Pia
Goutorbe, Frederic
Kerbrat, Jean-Baptiste
Leger, Damien
Lavergne, Florent
Monaca, Christelle
Monteyrol, Pierre-Jean
Morin, Laurent
Mullens, Eric
Pigearias, Bernard
Martin, Francis
Khemliche, Hauria
Lerousseau, Lionel
Meurice, Jean-Claude
Abedipour, Darius
Allard-Redon, Aurélie
Aranda, Alexandre
Attali, Valérie
Bavozet, Frédérique
Becu, Martine
Beruben, Wally
Bessard, Jerome
Bonafe, Isabelle
Boukhana, Mohammed
Chabrol, Bruno
Chatte, Gérard
Lebret, Chauvel
Collet, Jean-Marc
Coste, Olivier
Dumont, Nathalie
Durand-Amat, Sophie
D’ortho, Marie-Pia
Elbaum, Jean Marc
De Santerre, Olivier Gallet
Goutorbes, Frédéric
Grandjean, Thierry
Guyot, Wilma
Hammer, Doniphan
Havasi, Carmen
Huet, Pascal
Kerbrat, Jean Baptiste
Khemliche, Hauria
Koltes, Christian
Leger, Damien
Lacassagne, Laurent
Laur, Xavier
Lerousseau, Lionel
Liard, Olivier
Loisel, Christophe
Longuet, Matthieu
Mallart, Anne
Martin, Francis
Merle Beral, Frédéric
Meurice, Jean Claude
Mokhtari, Zoubida
Monaca, Christelle
Monteyrol, Pierre Jean
Muir, Jean-François
Mullens, Eric
Muller, Dominique
Paoli, Charles
Petit, François Xavier
Pigearias, Bernard
Pradines, Marc
Prigent, Arnauld
Putterman, Gil
Rey, Marc
Samama, Mickael
Tamisier, Renaud
Tiberge, Michel
Tison, Cyrille
Tordjman, Fabienne
Triolet, Bernard
Vacher, Christian
Vecchierini, Marie-Françoise
Verain, Alain
Funding for this research was provided by:
RESMED
Article History
Received: 11 August 2018
Revised: 2 November 2018
Accepted: 27 November 2018
First Online: 22 December 2018
Compliance with ethical standards
:
: The ORCADES study and the preparation of this article were funded by ResMed (France).
: Marie-Francoise Vecchierini has received fees for serving on advisory boards and lecture fees from ResMed and Fisher & Paykel Healthcare. Valérie Attali has received fees for serving on advisory boards from Somnomed, and lecture fees and unrestricted grant support from ResMed. Marie-Pia d’Ortho has received fees for serving on advisory boards from ResMed and IP Santé; lecture fees from ResMed, Philips, IP Santé, and VitalAire; grant support from Fisher and Paykel Healthcare, ResMed, Philips, ADEP-Assistance, and IP Santé; and small material donations from VitalAire. Damien Léger has been a primary investigator for studies sponsored by Vitalair and Philips over the last 5 years and declares no other conflicts of interest regarding this publication. Florent Lavergne is an employee of ResMed. Christelle Monaca has received fees for serving on advisory boards from ResMed, Philips and UCB Pharma, and lecture fees from UCB Pharma and Orkyn. Laurent Morin is an employee of ResMed. Francis Martin has received lecture fees from ResMed, Philips, ADEP-ASSISTANCE; grant support from ResMed, Philips, ADEP Assistance, Orkyn and France-Oxygène; and small material donations from ADEP-ASSISTANCE. Jean-Claude Meurice has received fees for serving on advisory boards, lectures, and training sessions from ResMed, Philips, Orkin, and Novartis. For the remaining authors, none were declared.
: The trial received ethics committee approval on December 17, 2010. All procedures performed in this study were in accordance with the international and national ethical standards and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: All patients gave written informed consent to participate in the study.